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Abstract
We performed this retrospective case-control study analyzing 428 first-attempt in vitro fertilization (IVF) cycles,
among which 254 involved women with a previous or present diagnosis of ovarian endometriosis. First, the results
of these 254 cycles were compared with 174 cycles involving patients with proven non-endometriotic tubal
infertility having similar age and body mass index. Women with ovarian endometriosis had a significantly higher
cancellation rate, but similar pregnancy, implantation and delivery rates as patients with tubal infertility. Second,
among the women with ovarian endometriosis, the women with a history of laparoscopic surgery for ovarian
endometriomas prior to IVF and no visual endometriosis at ovum pick-up (n = 112) were compared with the non-
operated women and visual endometriomas at ovum pick-up (n = 142). Patients who underwent ovarian surgery
before IVF had significantly shorter period, lower antral follicle count and required higher gonadotropin doses than
patients with non-operated endometriomas. The two groups of women with a previous or present ovarian
endometriosis did, however, have similar pregnancy, implantation and live birth rates. In conclusion, ovarian
endometriosis does not reduce IVF outcome compared with tubal factor. Furthermore, laparoscopic removal of
endometriomas does not improve IVF results, but may cause a decrease of ovarian responsiveness to
gonadotropins.
Background
Laparoscopic stripping of endometriomas before IVF/
ICSI treatment in order to improve its outcome is wide-
spread in everyday clinical practice. This procedure is,
however, not based on clinical evidence[1-3]. Although
a previous metanalysis [4], showed reduced pregnancy
rates after IVF in women with ovarian endometriosis
compared to patients undergoing IVF for other indica-
tions [5], other later studies could not confirm this find-
ing [6-9]. When the influence of the surgical removal of
endometriomas on IVF outcome was studied, operated
patients obtained IVF results comparable to women
without previous surgical intervention [10-15]. Further-
more, some results suggest that the surgical intervention
may have a negative effect on ovarian reserve [12,16-18]
and hence putatively compromise treatment outcome
and long-term fertility.
Thus, the possible impact of ovarian endometriosis on
ART results remain a controversial issue. The aim of
the present study was to retrospectively analyze a large
number of IVF/ICSI cycles and to evaluate the treat-
ment outcome (a) in patients with a diagnosis of ovarian
e n d o m e t r i o s i si nc o m p a r i s o nt ot h a ti np a t i e n t sw i t h
tubal infertility and (b) in women with a history of
laparoscopic removal of ovarian endometriomas prior to
IVF compared with the outcome in women without pre-
vious surgical intervention and a visual endometrioma
at OPU.
Methods
Patients
A total number of 8623 first-attempt IVF cycles per-
formed in three IVF units were retrospectively analyzed.
In total, 254 cycles were found to involve women diag-
nosed with ovarian endometriosis. Of these, 142 women
had never undergone any ovarian surgery and displayed
one or more in situ ovarian endometriomas of small to
medium size (< = 6 cm in diameter; Group A), and 112
women underwent IVF after the laparoscopic removal of
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cm in diameter) by the classical “stripping” technique
(Group B). These women did not have visual endome-
triomas at the time of OPU. The proportion of patients
with bilateral endometriomas was 14.1% in Group A (20
out of 142) and 19.6% in group B (22 out of 112), a dif-
ference not statistically significant. In case of bilateral or
multiple endometriomas, their diameter was summed: in
all cases, the total diameter did not exceed 6 cm. Endo-
metriosis patients in Group B were operated because
they were symptomatic, whereas those in Group A were
not operated before IVF because they were no or less
symptomatic, although they had endometriomas of simi-
lar size.
In all patients submitted to laparoscopic ovarian resec-
tion, the diagnosis of ovarian endometriosis was histolo-
gically confirmed. In women who had not been
operated before IVF (Group A), the diagnosis of ovarian
endometriosis was based on transvaginal ultrasound
(evidence of an adnexal mass with diffuse low level
echoes without neoplastic or acute hemorrhage features;
[19]) and the AFS stage was estimated to be II-III in all
cases. None of the patients operated for ovarian endo-
metriosis received GnRH-agonists or other medical
treatments prior to or after operation.
The control group consisted of 174 women who
underwent IVF treatment during the same time period,
with laparoscopically diagnosed tubal factor and without
any evidence of ovarian endometriosis. These women
covered similar ranges of age and BMI as the endome-
triosis patients (Group C).
IVF procedure
Ovarian stimulations were conducted with daily subcu-
taneous injections of individual starting doses of rFSH
(Follitropin alfa (Merck-Serono, Geneva, Switzerland)
or Follitropin beta (Organon, Oss, the Netherlands) or
hMG (Meropur/Menopur, Ferring, Switzerland) at
appropriate doses (100-450 IU), estimated according to
the woman’sage, the antral follicle count and the basal
(day 3) FSH. The long GnRH-agonist down-regulation
protocol was used (Nafarelin-Pfizer Inc., New York,
USA) 400 mg nasally twice daily, or buserelin (Sanofi-
Aventis, Paris, France) 0.3 mg nasally four times daily);
in both cases half the dose was administered during
ovarian stimulation. Ovarian response to gonadotro-
pins was monitored by transvaginal ultrasound plus
serum E2 measurement every third day from stimula-
tion day 7. Ovulation was triggered by injecting 10,000
IU hCG s.c. when the leading follicle reached 18 mm,
with appropriate serum E2 levels. Transvaginal ultra-
sound-guided oocyte aspiration (OPU) was performed
approximately 36 hours after hCG injection under
local anaesthesia (paracervical block). Either IVF or
ICSI was performed according tothe clinical indication.
After cultivation, embryos were transferred on Day 2
or 3 after ovum pick-up (OPU). Luteal phase support
was given vaginally to all patients for 2 weeks from
embryo transfer (progesterone vagitories (Apoteket AB,
Stockholm, Sweden) 1200 mg or gel (Merck-Serono,
Geneva, Switzerland) 180 mg daily). Pregnancy was
defined as the visualization of a gestational sac at vagi-
nal ultrasound investigation in gestational week 7. All
data were de-identified ahead of analysis. The study
did not in any way alter our routine IVF/ICSI proto-
cols, nor did it involve any additional intervention at
treatment. All data were prospectively collected with
the intention to evaluate impact on treatment
outcome.
Ovarian surgery technique
A four-port laparoscopy technique was used: an 11 mm
trocar was inserted through a short umbilical incision
and connected to a video monitor (WideVieuw™HD
Karl Storz Endoscope); two additional lateral 5 mm
operating ports and a central sovrapubic 5-10 mm oper-
ating port were also inserted. The pneumo-peritoneum
was achieved by inflating CO2 (10 mmHg).
To excide endometriomas, an incision was performed
at the antimesenteric site of the affected ovary using
bipolar cautery; then, the endometrioma was drained
with aspiration and the pseudo-capsule was dissected
by gentle traction and countertraction using two 5 mm
grasping forceps ("stripping”). The bleeding at the
stripping site was stopped by bipolar cautery, only
when necessary and very carefully in order to avoid
unnecessary thermal damage to the healthy ovarian
tissue.
Assessment of ovarian sensitivity to FSH
To assess ovarian sensitivity to FSH, the ratio between
the number of retrieved oocytes and the number of FSH
IU (x100) was calculated. This variable was defined
“ovarian sensitivity”,a si ts h o w st h ee f f e c t i v eo v a r i a n
response to FSH stimulation, independently on the total
amount of administered FSH. Patients with more abun-
dant ovarian follicular reserve tend to display higher
ovarian sensitivity to exogenous FSH, whereas women
with a low ovarian reserve usually have a lower ovarian
sensitivity.
Statistical analysis
Data are expressed as the mean ± SEM or as percen-
tages when required. Statistical comparisons among
groups were performed using the Fisher exact test,
Yeats’ corrected c
2,W i l c o x o n ’s test or Student’stt e s t ,
as appropriate. The JMP software was used for statistical
elaboration. Significance was defined as a p value < 0.05.
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IVF outcome in patients with ovarian endometriosis vs.
patients with tubal factor
The basal characteristics of patients with ovarian endo-
metriosis (Group A), previously operated of endome-
trioma excision (Group B) and tubal infertility (Group
C, controls) are shown in Table 1.
T h eg r o u p sw e r ec o m p a r a b l ef o ra g e ,B M I ,i n f e r t i l i t y
duration, smoking habits, mean period, prevalence of
associated male factor, and basal (day 3) FSH levels. The
basal antral follicle count was significantly lower in
women previously submitted to the excision of ovarian
endometriosis (Group B) than in women with ovarian
endometrioma(s) (Group A) or tubal factor infertility
(Group C).
The outcome of IVF in patients affected by ovarian
endometriosis versus woman with tubal factor is shown
in Table 2. Women with ovarian endometriosis showed
a significantly higher cancellation rate, but those who
completed ovarian stimulation had a similar yield of
oocytes at OPU and a comparable ovarian sensitivity
compared to control subjects. Fertilization rates were
similar, but women with endometriosis showed a lower
percentage of cycles with complete failure of fertilisa-
tion. Overall, the implantation, pregnancy and live-birth
rates per started cycle, OPU, and ET were similar in the
groups.
IVF outcome in patients with in situ ovarian
endometrioma(s) vs. patients previously operated for
ovarian endometrioma(s)
The clinical characteristics of patients having one or
more in situ ovarian endometriomas at the time of IVF
(Group A) and of women who had been previously
operated for endometrioma removal (Group B) are
shown in Table 1. Operated women had a shorter mean
period and lower antral follicle counts than women with
in situ endometrioma(s).
Women with previous ovarian surgery required higher
total FSH doses than patients without previous surgery,
but had comparable numbers of oocytes at OPU (Table
2). Thus, ovarian sensitivity was lower in operated
women. The implantation rate, pregnancy rate and live-
birth rate per started cycle, OPU, and ET were similar
in the two groups.
Discussion
The present study retrospectively analyzed a large
cohort of patients undergoing IVF in the years 2004-
2009, identifying 254 patients with a previous or present
diagnosis of ovarian endometriosis. With the limitations
of a retrospective study (although on a remarkably large
number of observations), our results suggest that pre-
vious or present ovarian endometriosis does not impair
success rates at IVF/ICSI, and that ovarian surgery for
endometriosis does not result in improved ART out-
c o m e ,b u t ,o nt h ec o n t r a r y ,m a yc o m p r o m i s eo v a r i a n
reserve.
Laparoscopic stripping of ovarian endometriomas as
an intervention to improve fertility is a widespread clini-
cal practice, not only to improve natural fertility, but
also to improve IVF outcome. This surgical strategy is
used because of the following reasons: a) older studies
suggested that patients with ovarian endometriosis had
poorer IVF outcome than women with other infertility
causes; b) some data suggest that spontaneous fecundity
may improve after laparoscopic cystectomy [1]; c) some
argue that puncturing an endometrioma during oocyte
retrieval could spread endometriotic cells in the abdom-
inal cavity or cause a pelvic infection.
The risk of complications linked to the puncture of
ovarian endometriomas is, however, minimal: infec-
tions have been reported only sporadically [20,21], and
indeed a study in which ovarian endometriomas were
intentionally punctured and aspirated at the time of
oocyte retrieval reported no complications [22].
Furthermore, aspiration of endometriomas followed by
local injection of methotrexate [23] or alcoholic solu-
tions [24,25] is considered a therapeutic option for
ovarian endometriosis.
As for IVF outcome in women with a diagnosis of
ovarian endometriosis, the published data exhibit vary-
ing results. A meta-analysis from 2002 including 22 stu-
dies showed a reduced pregnancy rate after IVF in
women with endometriosis compared to treatments in
women with other infertility causes, and also showed a
linear (inverse) relationship between the stage of the
Table 1 Clinical characteristics of patients having one or
more in situ endometrioma(s) at the time of IVF (Group
A) vs. those previously operated for laparoscopic
endometrioma(s) removal (Group B) vs. women with
tubal infertility (Group C, controls)
Group A Group B Group C p
Patients 142 112 174
Age (yrs) 33.8 ± 3.1 33.6 ±
4.4
34.0 ±
3.1
ns
BMI (kg/m
2) 22.7 ± 3.2 22.4 ±
3.2
23.1 ±
3.3
ns
Smoke (%) 11.8 16.1 15.3 ns
Mean period (days) 28.8 ± 4.0 27.2 ±
4.1
28.5 ±
3.1
< 0.005
1
< 0.004
2
Infertility duration (years) 4.0 ± 2.5 3.9 ± 2.9 3.6 ± 0.3 ns
Associated male factor
(%)
13.8 19.1 13.7 ns
Antral follicle count 16.9 ±
11.1
11.7 ±
9.4
16.6 ±
9.5
<
0.001
1,2
FSH day 3 level (U/l) 7.2 ± 3.9 7.9 ± 4.2 6.6 ± 3.5 ns
1Group A vs Group B,
2Group B vs Group C, ns: not significant.
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subsequent studies, including a large epidemiological
survey [9], reported similar IVF outcome in patients
with ovarian endometriosis as in women with other
infertility causes [6,8,26,27]. A recent study comparing
patients with endometriomas with women with non-
endometriotic ovarian cysts suggested that ovarian
endometriosis was associated with poorer embryo qual-
ity, although the pregnancy rate was unaffected [28].
Intervention studies investigating the effectiveness of
laparoscopic removal of ovarian endometriosis as a tool
to improve subsequent IVF results also show mainly
negative results. Several reports showed that the out-
come of IVF in patients previously submitted to laparo-
scopic stripping of endometriomas was similar to that of
endometriosis-free controls [27,29-32]. As these studies
did not include a group of patients with endometriomas
who had not been subject to surgery, the impact of
operating ovarian endometriosis per se could not be
evaluated. In line with our results, a recent metanalysis
showed that the outcome of IVF was similar in patients
with in situ ovarian endometriomas as in endometriosis-
free women [7]. In 30 infertile patients that served as
their own controls as they were treated with IVF both
before and after surgical treatment of ovarian endome-
triosis, Shahine [15] showed that embryo quality on day
3 was not improved after ovarian surgery, and IVF
results remained comparable to those obtained before
the operation. A recent meta-analysis including five
studies comparing surgery vs. no treatment of endome-
trioma before IVF showed that there was no significant
difference in the clinical pregnancy rate between the
operated and the non-operated patients [13]. Only the
study of Barri [33] reported a better IVF outcome in
patients with ovarian endometriosis previously sub-
mitted to ovarian surgery vs. patients undergoing IVF as
the first therapeutic option. Thus, most available data
clearly show that surgical management of endometrio-
mas gives no advantage for a subsequent IVF.
Our results showed that women operated for ovarian
endometriosis exhibited several markers of a reduced
ovarian reserve. Thus, cancellation rates, mean period
[34], antral follicle counts and ovarian sensitivity to
FSH/hMG were all reduced in the group of operated
women. These findings are well in line with previous
data. Patients previously submitted to laparoscopic
cystectomy required a higher gonadotropin dose to
achieve a similar ovarian response [12,16-18] or showed
a lower oocyte yield [12,14,32,35-37]. In women oper-
ated for a monolateral ovarian endometrioma, it was
reported that the operated ovary produced a lower num-
ber of follicles than the contralateral [38,39]. Indeed a
histologically proven loss of functional ovarian tissue
close to the cyst was well documented [40]. Moreover,
Tinkanen [10] reported that non-operated patients had
significantly more embryos and higher pregnancy and
live birth rates than operated women. In a prospective,
randomized trial, Demirol [12] showed that operated
Table 2 IVF outcome of patients having one or more in situ endometrioma(s) at the time of IVF (Group A) vs. those
previously operated for laparoscopic endometrioma(s) removal (Group B) vs. woman with tubal infertility (Group C,
controls)
Group A Group B Group C p
Cancellation rate (%) 7.5 9.8 2.9 < 0.02
2,3
Total FSH dose (IU) 2339 ± 1248 3298 ± 1404 2537 ± 1090 < 0.001
1,3
N. of retrieved oocytes 9.4 ± 4.3 8.2 ± 5.3 9.6 ± 4.0 < 0.03
3
MII oocytes (%) 71.2 68.8 66.9 ns
Ovarian sensitivity 5.6 ± 3.2 3.5 ± 3.5 5.0 ± 3.0 < 0.001
1,3
Type of treatment (%)
IVF 77 72 68 ns
ICSI 19 23 25 ns
Combined 457 n s
Fertilization rate (%) 67.7 73.4 70.2 ns
Cycles with no fertilization (%) 6.6 8.2 10.0 < 0.04
2
Number of embryos transferred 2.0 ± 0.5 2.1 ± 0.6 2.2 ± 0.4 ns
Pregnancy rate/ started cycle (%) 41.5 36.6 35.0 ns
Pregnancy rate/OPU (%) 45.0 40.6 36.1 ns
Pregnancy rate/ ET (%) 48.4 44.1 40.1 ns
Implantation rate (%) 24.2 24.6 22.1 ns
Live-birth rate/ET (%) 34.6 25.8 30.8 ns
1Group A vs Group B,
2Group B vs Group C,
3Group A vs Group C, ns: not significant.
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lation, obtained less oocytes and finally had similar IVF
outcome as women with in situ endometriomas.
Somigliana [14] reported that women operated for bilat-
eral endometriotic ovarian cysts and subsequently sub-
mitted to IVF had a higher withdrawal rate for poor
response, retrieved less oocytes despite the use of higher
doses of gonadotropins, and had significantly lower
pregnancy and delivery rates than non-endometriotic,
never operated on the ovary, controls.
In conclusion, with the limitations of a retrospective
study we show herein that the presence of ovarian endo-
metriosis is not a cause of poorer IVF outcome and that
laparoscopic stripping before IVF does not improve out-
come. On the contrary, the operation may reduce ovar-
ian reserve and increase the need for exogenous
hormones to retrieve an adequate number of oocytes,
thus increasing the overall cost of the treatment. Our
observations, in line with most recent data, add evidence
against laparoscopic ovarian surgery for endometriomas
in asymptomatic patients who are candidates for IVF.
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